Pfizer Hits Lupin With 2nd Suit Over Lyrica ANDA
Pfizer Inc. has launched another patent infringement suit against generic-drug maker Lupin Ltd. over its efforts to manufacture a copycat version of nerve pain drug Lyrica....To view the full article, register now.
Already a subscriber? Click here to view full article